Aarti Pharmalabs Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for AARTIPHARM, BSE:543748 Aarti Pharmalabs Ltd.

Search Inside the pdf :

Aarti Pharmalabs Ltd.

14 Nov 2025

742.50

-2.28%

Capacity expansion across segments to steer growth beyond FY26Xanthine segment primarily witnessed the growth on account of capacity debottlenecking of ~1000 MTPA thereby taking overall capacity to 6000 MTPA from 5000 MTPA. The company remains on track to expand its capacity to 9000 MTPA by Q4FY26. Prices of xanthine remained stable, as per management. We believe APL to focus more on grabbing the larger wallet share across Pharma and beverage customers (higher margin opportunities). On the CDMO front, the management is confident of achieving its guidance of 30-40% growth on back of strong order book...

Number of FII/FPI investors increased from 133 to 140 in Sep 2025 qtr.

RESEARCH REPORTS

Buy SEE REPORTS >

pdf